Competition is supposed to keep prices down, so why did the cost of emergency allergy treatment EpiPen continue to soar after the introduction of a competing product? Because, according to a new lawsuit, most of that added money was going to intermediaries who could make sure that EpiPen remained the preferred (and sometimes only) drug of its kind on insurance plans. [More]
kaleo
Lawsuit: EpiPen Price Hikes Were Intended To Keep Competitor Out Of Pharmacies
By 4.26.17 — Updated: 5.9.17
Senators Want To Know Why Price Of Lifesaving Drug Went From $690 To $4,500
By 2.8.17 — Updated: 2.17.17
As you’re probably all too aware, the U.S. is in the midst of an opioid epidemic, meaning that some life-saving overdose treatments have become crucial tools for hospitals, law enforcement, first responders, and families of addicts. At the same time, the makers of one such vital drug have raised the price by more than 600% since 2014, drawing the attention of lawmakers who want to know why. [More]
